This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Iqbal J, Al Qarni A. Metabolic syndrome, dyslipidemia and regulation of lipoprotein metabolism. Curr Diabetes Rev. 2017 Jul 5.IqbalJAl QarniAMetabolic syndrome, dyslipidemia and regulation of lipoprotein metabolismCurr Diabetes Rev2017Jul 510.2174/157339981366617070516103928677496Search in Google Scholar
Chen C, Jing G. Insulin resistance and polycystic ovary syndrome in a chinese population. Endocr Pract. 2017 Jul 6.ChenCJingGInsulin resistance and polycystic ovary syndrome in a chinese populationEndocr Pract2017Jul 610.4158/EP171849.OR28683241Search in Google Scholar
Leite PB, Dâmaso AR. Long-term interdisciplinary therapy decreases symptoms of binge eating disorder and prevalence of metabolic syndrome in adults with obesity. Nutr Res. 2017 Apr;40:57-64.2847306110.1016/j.nutres.2017.03.006LeitePBDâmasoARLong-term interdisciplinary therapy decreases symptoms of binge eating disorder and prevalence of metabolic syndrome in adults with obesityNutr Res201740576428473061Search in Google Scholar
Al-Dughaishi T, Nikolic D. Nutraceuticals as Lipid-Lowering Treatment in Pregnancy and Their Effects on the Metabolic Syndrome. Curr Pharm Biotechnol. 2016;17(7):614-23.2703350610.2174/1389201017666160401145817Al-DughaishiTNikolicDNutraceuticals as Lipid-Lowering Treatment in Pregnancy and Their Effects on the Metabolic SyndromeCurr Pharm Biotechnol20161776142327033506Search in Google Scholar
Dong D, Reece EA. New development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defects. Am J Obstet Gynecol. 2016 Feb;214(2):192-202.2643246610.1016/j.ajog.2015.09.082DongDReeceEANew development of the yolk sac theory in diabetic embryopathy: molecular mechanism and link to structural birth defectsAm J Obstet Gynecol20162142192202474454526432466Search in Google Scholar
Greene ND, Leung KY, Copp AJ. Inositol, neural tube closure and the prevention of neural tube defects. Birth Defects Res. 2017 Jan 30;109(2):68-80.2732455810.1002/bdra.23533GreeneNDLeungKYCoppAJInositol, neural tube closure and the prevention of neural tube defectsBirth Defects Res2017Jan 3010926880535366127324558Search in Google Scholar
Farren M, Daly N. The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. Diabetes Care. 2017 Jun;40(6):759-763.2832578410.2337/dc16-2449FarrenMDalyNThe Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled TrialDiabetes Care201740675976328325784Search in Google Scholar
Brown J, Crawford TJ. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. Cochrane Database Syst Rev. 2016 Sep 7;9:CD012048.27602537BrownJCrawfordTJDietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetesCochrane Database Syst Rev2016Sep 7;9:CD01204810.1002/14651858.CD012048.pub2645769227602537Search in Google Scholar
Malvasi A, Casciaro F. Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. Eur Rev Med Pharmacol Sci. 2014;18(2):270-424488919MalvasiACasciaroFMyo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigationEur Rev Med Pharmacol Sci20141822704Search in Google Scholar
Singh CK, Kumar A. Diabetic complications in pregnancy: is resveratrol a solution? Exp Biol Med (Maywood). 2013 May;238(5):482-90.2343688310.1177/1535370212473704SinghCKKumarADiabetic complications in pregnancy: is resveratrol a solution?Exp Biol Med (Maywood)2013238548290450125123436883Search in Google Scholar
Malvasi A, Kosmas I. Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? Clin Ter. 2017 Jul-Aug;168(4):e240-e247.28703838MalvasiAKosmasICan trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients?Clin Ter2017Jul-Aug1684e240e247Search in Google Scholar
Timmers S, Konings E. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011 Nov 2;14(5):612-22.10.1016/j.cmet.2011.10.00222055504TimmersSKoningsECalorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humansCell Metab2011Nov 214561222388086222055504Open DOISearch in Google Scholar
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertil Steril. 2012 Jan;97(1):28-38.e25.FauserBCTarlatzisBCRebarRWLegroRSBalenAHLoboRCarminaEChangJYildizBOLavenJSBoivinJPetragliaFWijeyeratneCNNormanRJDunaifAFranksSWildRADumesicDBarnhartKConsensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertil Steril2012971283810.1016/j.fertnstert.2011.09.02422153789Search in Google Scholar
Baillargeon JP, Iuorno MJ, Nestler JE. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol. 2003 Jun;46(2):325-40. Review.10.1097/00003081-200306000-0001112808383BaillargeonJPIuornoMJNestlerJEInsulin sensitizers for polycystic ovary syndromeClin Obstet Gynecol20034623254012808383Open DOISearch in Google Scholar
Højlund K. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Dan Med J. 2014 Jul;61(7):B4890. Review.25123125HøjlundK.Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistanceDan Med J2014617B4890Search in Google Scholar
De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update.. Reprod Biol Endocrinol. 2016 Jul 16;14(1):382742318310.1186/s12958-016-0173-xDe LeoVMusacchioMCCappelliVMassaroMGMorganteGPetragliaFGenetic, hormonal and metabolic aspects of PCOS: an updateReprod Biol Endocrinol2016Jul 1614138494729827423183Search in Google Scholar
Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update. 2011;17:17-33.10.1093/humupd/dmq03220639519QiaoJFengHLExtra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceHum Reprod Update2011171733300133820639519Open DOISearch in Google Scholar
Toprak S, Yönem A, Cakir B, Güler S, Azal O, Ozata M, Corakçi A. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res. 2001;55(2):65-70.11509861ToprakSYönemACakirBGülerSAzalOOzataMCorakçiAInsulin resistance in nonobese patients with polycystic ovary syndromeHorm Res2001552657010.1159/00004997211509861Search in Google Scholar
Larner J. D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res 2002; 3: 47-60.1190027910.1080/15604280212528LarnerJD-chiro-inositol-its functional role in insulin action and its deficit in insulin resistanceInt J Exp Diabetes Res200234760247856511900279Search in Google Scholar
Nestler J, Unfer V. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol Endocrinol 2015; 31: 501-505.2617709810.3109/09513590.2015.1054802NestlerJUnferVReflections on inositol(s) for PCOS therapy: steps toward successGynecol Endocrinol20153150150526177098Search in Google Scholar
Larner J, Huang LC, Tang G, Suzuki S, Sch wartz CF, Romero G, Roulidis Z, Zeller K, Shen TY , Oswald AS. Insulin mediators: structure and formation. Cold Spring Harb Symp Quant Biol 1988; 53: 965-97.10.1101/SQB.1988.053.01.1113076102LarnerJHuangLCTangGSuzukiSSch wartzCFRomeroGRoulidisZZellerKShenTYOswaldASInsulin mediators: structure and formationCold Spring Harb Symp Quant Biol19885396597Open DOISearch in Google Scholar
Dresner A., Laurent D., Marcucci M., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. Journal of Clinical Investigation. 1999;103(2):253-259.10.1172/JCI5001DresnerA.LaurentD.MarcucciM.et alEffects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activityJournal of Clinical Investigation199910322532594078809916137Open DOISearch in Google Scholar
Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, Granese R, Triolo O.Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols. Int J Endocrinol. 2016;2016:6306410.27579037LaganàASRossettiPBuscemaMLaVignera SCondorelliRAGulloGGraneseRTrioloO.MetabolismOvarianFunctionin PCOS Women: A Therapeutic Approach with InositolsInt J Endocrinol20162016630641010.1155/2016/6306410498907527579037Search in Google Scholar
Pizzo A, Lagan`a AS, and Barbaro A, Comparison betweeneffects ofmyo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS, Gynecological Endocrinology 2014; 30 (3), 205-208.10.3109/09513590.2013.860120PizzoALagan`aASBarbaroAComparison betweeneffects ofmyo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOSGynecological Endocrinology201430320520824351072Open DOISearch in Google Scholar
Nonomura S, Kanagawa H, Makimoto A. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-J O-Kon. Polygonum cuspidatum Sieb Et Zucc Yakugaku Zasshi 1963; 83 988-990.NonomuraSKanagawaHMakimotoAChemical constituents of polygonaceous plantsI. Studies on the components of Ko-J O-Kon. Polygonum cuspidatum Sieb Et Zucc Yakugaku Zasshi19638398899010.1248/yakushi1947.83.10_988Search in Google Scholar
Howitz KT, Bitterman KJ, Cohen HY, Lamming DW,. Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature 2003; 425 191-196.10.1038/nature0196012939617HowitzKTBittermanKJCohenHYLammingDWLavuSWoodJGZipkinREChungPKisielewskiAZhangLLet alSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature200342519119612939617Open DOISearch in Google Scholar
Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010 Mar;59(3):554-63.1993400710.2337/db09-0482UmJHParkSJKangHYangSForetzMMcBurneyMWKimMKViolletBChungJHAMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrolDiabetes201059355463282864719934007Search in Google Scholar
Hardie DG. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262.10.1038/nrm331122436748HardieDGAMPK: a nutrient and energy sensor that maintains energy homeostasisNat. Rev. Mol. Cell Biol13251262572648922436748Open DOISearch in Google Scholar
Chung JH, Manganiello V, Dyck JR. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 2012; 22(10):546-54.10.1016/j.tcb.2012.07.00422885100ChungJHManganielloVDyckJRResveratrol as a calorie restriction mimetic: therapeutic implicationsTrends Cell Biol2012221054654346223022885100Open DOISearch in Google Scholar
Zang M. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180-2191.1687368010.2337/db05-1188ZangMPolyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient miceDiabetes552180219116873680Search in Google Scholar
Chan V, Fenning A, Iyer A, Hoey A, Brown L. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Current Pharmaceutical Biotechnology. 2011;12(3):429-436.10.2174/138920111794480552ChanVFenningAIyerAHoeyABrownLResveratrol improves cardiovascular function in DOCA-salt hypertensive ratsCurrent Pharmaceutical Biotechnology201112342943620874677Open DOISearch in Google Scholar
Joshi MS, Williams D, Horlock D, Samarasinghe T, Andrews KL, Jefferis AM, Berger PJ, Chin-Dusting JP, Kaye DM. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol. Diab Vasc Dis Res. 2015 May;12(3):208-16.2576718110.1177/1479164114565629JoshiMSWilliamsDHorlockDSamarasingheTAndrewsKLJefferisAMBergerPJChin-DustingJPKayeDMRole of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrolDiab Vasc Dis Res20151232081625767181Search in Google Scholar
Zhu KN, Jiang CH. Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation. Phytomedicine. 2015 Aug 15;22(9):837-46.10.1016/j.phymed.2015.05.05826220631ZhuKNJiangCHTwo triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activationPhytomedicine2015Aug 152298374626220631Open DOISearch in Google Scholar
Wang S, Song P, Zou MH. AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci (Lond). 2012 Jun;122(12):555-73.2239019810.1042/CS20110625WangSSongPZouMHAMP-activated protein kinase, stress responses and cardiovascular diseasesClin Sci (Lond)20121221255573336796122390198Search in Google Scholar
